tradingkey.logo
搜尋

Xtant Medical Holdings Inc

XTNT
添加自選
0.320USD
-0.007-2.14%
收盤 09-18 16:00美東
45.59M總市值
24.70本益比TTM
盤後交易 16:10 (美東)0.320USD-0.005-1.54%

關於 Xtant Medical Holdings Inc 公司

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Xtant Medical Holdings Inc 簡介

公司代碼XTNT
公司名稱Xtant Medical Holdings Inc
上市日期Jun 30, 2010
CEOBrowne (Sean E)
員工數量217
證券類型Ordinary Share
年結日Jun 30
公司地址664 Cruiser Lane
城市BELGRADE
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編59714
電話14063880480
網址https://xtantmedical.com/
公司代碼XTNT
上市日期Jun 30, 2010
CEOBrowne (Sean E)

Xtant Medical Holdings Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer, Assistant Secretary
Chief Financial Officer, Assistant Secretary
742.11K
+50.11%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer, Assistant Secretary
Chief Financial Officer, Assistant Secretary
742.11K
+50.11%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer, Assistant Secretary
Chief Financial Officer, Assistant Secretary
742.11K
+50.11%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
373.75K
+57.66%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%

常見問題

Xtant Medical Holdings Inc的前五大股東是誰?

Xtant Medical Holdings Inc的前五大股東如下:Mr. Stavros G. Vizirgianakis

哪個業務部門對Xtant Medical Holdings Inc的收入貢獻最大?

在2026Q4,Orthobiologics業務部門對Xtant Medical Holdings Inc的收入貢獻最大,創收17.36M,占總收入的75.38% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有